SPARC is a VCAM-1 counter-ligand that mediates leukocyte transmigration
VCAM‐1 is a cell surface molecule, which has been shown to mediate leukocyte adhesion to the endothelium and subsequent transmigration. Although VCAM‐1 regulates adhesion through its interaction with VLA‐4, VLA‐4 does not play a role in VCAM‐1‐dependent diapedesis, an observation suggesting the pres...
Saved in:
Published in: | Journal of leukocyte biology Vol. 81; no. 3; pp. 748 - 756 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
United States
Society for Leukocyte Biology
01-03-2007
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | VCAM‐1 is a cell surface molecule, which has been shown to mediate leukocyte adhesion to the endothelium and subsequent transmigration. Although VCAM‐1 regulates adhesion through its interaction with VLA‐4, VLA‐4 does not play a role in VCAM‐1‐dependent diapedesis, an observation suggesting the presence of a second ligand for VCAM‐1. We now report a novel interaction between VCAM‐1 and secreted protein acidic and rich in cysteine (SPARC), which induces actin cytoskeletal rearrangement and intercellular gaps, physiological processes known to be important for leukocyte transmigration. The binding of leukocyte‐derived SPARC to VCAM‐1 was demonstrated to be necessary for leukocyte transmigration through endothelial monolayers (diapedesis) in vitro, and furthermore, SPARC null mice have abnormalities in leukocyte recruitment to the inflamed peritoneum in vivo. These findings provide new insight into the mechanisms of transendothelial leukocyte migration and suggest a potential, targetable interaction for therapeutic intervention. |
---|---|
Bibliography: | These authors contributed equally to this work. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0741-5400 1938-3673 |
DOI: | 10.1189/jlb.1105664 |